Updated:
Hydreight Technologies
Hydreight Technologies gives 2,500+ nurses the regulatory and pharmacy backbone to run independent mobile IV and injection practices in all 50 states.
Hydreight Technologies
Hydreight Technologies launched in 2019 under CEO Shane Madden, headquartered in Vancouver with its operational engine focused entirely on the United States. The business is not a healthcare provider; it is a technology and pharmacy platform that gives registered nurses and other licensed practitioners the legal, pharmacy, and administrative infrastructure to deliver IV therapy, vitamin injections, and other wellness services directly to consumers at home or in hotel rooms. The company went public on the TSX Venture Exchange in December 2022 (per public record, 2022). The company's strategy sits at the intersection of telehealth regulation and the direct-to-consumer wellness boom. Hydreight generates revenue through a platform subscription fee paid by its network of independent nurse practitioners, plus a markup on compounded medications and medical supplies fulfilled through a proprietary 503A pharmacy network. The platform covers all 50 states, supported by a national medical director network that provides the standing orders and collaborative agreements nurses need to practice independently. The service menu is narrow — principally IV hydration, vitamin drips, and injectable weight-loss and wellness medications — but the regulatory scaffolding that makes it legal for a nurse to administer an IV in a hotel room is the real asset. The firm trades publicly under the symbol NURS on the TSX Venture Exchange and also files with the SEC. It operates through its wholly owned U.S. subsidiary, Hydreight Inc., based in Nevada. As a public company, its financials are subject to continuous disclosure. In 2024, the company expanded its pharmacy network and deepened integration with GLP-1 prescribing protocols to ride the surge in telemedicine-driven weight-loss care (per the firm's official communications, 2024). Hydreight's structural differentiator is regulatory arbitrage codified as a technology platform. It does not employ the nurses, bill insurance, or own clinics. It provides the legal framework — standing orders from a medical director in every state — that transforms individual practitioners into mobile point-of-care units. This liability-light, franchise-like model means the company scales with nurse recruitment, not facility leases, giving it a fundamentally different cost structure from urgent care chains or traditional home-health agencies.
General information
Firm type
other
Year founded
2019
AUM
Undisclosed
Location
Region
North America
Country
Canada
City
Vancouver
Corporate office
Vancouver, BC, Canada
Principals
Shane Madden
Chief Executive Officer
Sector focus
Frequently asked questions
How does Hydreight Technologies generate revenue?
Hydreight earns revenue primarily through two channels: subscription fees from the independent healthcare professionals who use its platform, and product margins on the compounded medications and medical supplies dispensed through its proprietary 503A pharmacy network. Nurses pay to access the legal framework, standing orders, and pharmacy fulfillment, while Hydreight captures a spread on every IV bag or injectable shipped.
Does Hydreight directly employ the nurses on its platform?
No. The nurses and other licensed practitioners on the Hydreight platform are independent contractors who run their own businesses. Hydreight provides the technology, regulatory infrastructure, standing orders through a national medical director network, and pharmacy fulfillment. This structure keeps labor costs off Hydreight's balance sheet and makes the model highly scalable.
What does the national medical director network actually do?
In the U.S., registered nurses cannot administer IV therapies without a physician's standing order. Hydreight maintains a network of medical directors across all 50 states who provide those standing orders and collaborative agreements, creating a compliant legal framework that allows a nurse to operate independently in a mobile setting. This regulatory infrastructure is the core intellectual property of the platform.
What specific services does a Hydreight nurse typically offer?
The platform focuses on elective wellness services: IV hydration drips, vitamin injections (B12, MIC, etc.), and injectable medications including GLP-1 agonists for weight loss. Nurses also offer NAD+ therapy, hangover recovery drips, and beauty injections. The service catalog is deliberately narrow to stay within the bounds of what can be delivered by a nurse under standing orders without a physician present.
How is Hydreight different from a traditional home-health company?
Traditional home-health agencies employ their nurses, bill Medicare or private insurance, and treat patients with medical necessity. Hydreight does none of these things. It is a cash-pay, elective wellness platform that provides the legal and pharmacy rails for independent nurses to offer IV and injection services. It carries no receivables risk from insurers and does not touch patient care directly.
What is Hydreight's relationship to the 503A compounding pharmacy network?
Hydreight owns or partners with 503A compounding pharmacies that produce patient-specific medications prescribed through the platform's telemedicine workflows. These pharmacies supply the IV bags, injectables, and supplies that nurses order for each appointment. The 503A designation is critical: it allows compounding of medications tailored to individual patients without the more onerous FDA registration required for 503B outsourcing facilities.
On which stock exchange does Hydreight trade, and when did it go public?
Hydreight Technologies trades on the TSX Venture Exchange under the symbol NURS, and its shares also trade on the OTCQB in the United States. The company went public in December 2022 via a reverse takeover of a capital pool company, a common path for emerging Canadian companies to access public markets without a traditional IPO.
Profile maintained by Altss using OSINT (open-source intelligence), regulatory filings, licensed data partners, and verified direct submissions. Read the methodology. Last updated: . Continuous refresh with full update cycles at least every 30 days.
Need institutional-grade insight on family offices?
Altss delivers:
Prefer a guided tour?
We’ll walk you through: